Tag: Psychiatry Testimony

• How Do You Define “Expert?”

Posted on by

How Do You Define “Expert?” Neil S. Kaye, MD, DLFAPA Graham Glancy, MB, ChB, FRC Psych, FRCP Neil S. Kaye, MD, DFAPA and Graham Glancy, MB, ChB, FRC Psych, FRCP Continue Reading

• Effect of Open-Label Lamotrigine as Monotherapy and Adjunctive Therapy on the Self-Assessed Cognitive Function Scores of Patients With Bipolar I Disorder

Posted on by

This page may not display properly in all browsers. The PDF can be downloaded Brief Report Effect of Open-Label Lamotrigine as Monotherapy and Adjunctive Therapy on the Self-Assessed Cognitive Function Continue Reading

• An Open-Label Trial of Donepezil (Aricept) in the Treatment of Persons With Mild Traumatic Brain Injury

Posted on by
An Open-Label Trial of Donepezil (Aricept) in the Treatment of Persons With Mild Traumatic Brain Injury

• Recognizing, managing and treating Bipolar Disorders at the interface of Primary Care and Psychiatric Medicine (All Key PDF Page)

Posted on by
Recognizing, managing and treating Bipolar Disorders at the interface of Primary Care and Psychiatric Medicine

■ Ziprasidone Augmentation of Clozapine (All Key Txt)

Posted on by

Alan Greenberg, MD Editor-in-Chief The Journal of Clinical Psychiatry Box 752870 Memphis, TN 38175-2870 07/02/02 Ziprasidone augmentation of Clozapine To The Editor: Clozapine, the oldest atypical antipsychotic remains the “gold Continue Reading